Report - 2024 02 20 A31985 D271770 Bill Report 1097 S E Sbr Bfgt Ta 24
- Issuer
- Congressional materials
- Document type
- Report
- Date
- 2024-02-20
- Case
- 2024 02 20 A31985 D271770 Bill Report 1097 S E Sbr Bfgt Ta 24
Summary
A Senate Bill Report on ESHB 1097, as of February 15, 2024, prepared by non-partisan staff of the Senate Committee on Business, Financial Services, Gaming & Trade, for an act relating to the sale of cosmetics tested on animals. The bill is sponsored by the House Committee on Consumer Protection & Business and passed the House 90-3. The report gives background on the Federal Food, Drug, and Cosmetic Act and lists eleven states with laws prohibiting sale of cosmetics developed using animal testing. It summarizes the bill, which prohibits manufacturers from selling such cosmetics beginning January 1, 2025, sets out exceptions, and provides fines up to $5,000 for each violation. The four-page report ends with a staff summary of public testimony in favor of the bill.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
Cite this document
“Report - 2024 02 20 A31985 D271770 Bill Report 1097 S E Sbr Bfgt Ta 24.”
Original at app.leg.wa.gov, dated 2024-02-20. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/2024-02-20-2024-02-20-a31985-d271770-bill-report-1097-s-e-sbr-bfgt-ta-24/
, SHA-256 72b52d81754a5576de54e17bb99e666c7e585206e1114aae5dab0b49f45d65c0.Full text
SENATE BILL REPORT
ESHB 1097
As of February 15, 2024
Title: An act relating to the sale of cosmetics tested on animals.
Brief Description: Concerning the sale of cosmetics tested on animals.
Sponsors: House Committee on Consumer Protection & Business (originally sponsored by
Representatives Walen, Goodman, Leavitt, Ramel, Peterson, Fitzgibbon, Macri, Simmons,
Reeves, Thai, Gregerson, Stonier, Pollet, Kloba, Santos and Ormsby).
Brief History: Passed House: 1/25/24, 90-3.
Committee Activity: Business, Financial Services, Gaming & Trade: 2/15/24.
Brief Summary of Bill
• Establishes that it is unlawful for manufacturers to sell a cosmetic
developed or manufactured using cosmetic animal testing that was
conducted or contracted for by the manufacturer or its supplier, subject
to exceptions.
• Establishes fines for manufacturer violations up to $5,000 per violation.
SENATE COMMITTEE ON BUSINESS, FINANCIAL SERVICES, GAMING & TRADE
Staff: Clint McCarthy (786-7319)
Background: The Federal Food, Drug, and Cosmetic Act (FDCA) directs the Food and
Drug Administration (FDA) to ensure that cosmetics are safe and properly labeled. The
FDCA does not specifically require the use of animals in testing cosmetics for safety nor
does the FDCA subject cosmetics to FDA premarket approval. The FDA does not certify
claims such as "Cruelty-Free" or "Not Tested on Animals" on cosmetic labeling.
To date, eleven states have enacted laws prohibiting manufacturers from selling cosmetic
This analysis was prepared by non-partisan legislative staff for the use of legislative
members in their deliberations. This analysis is not part of the legislation nor does it
constitute a statement of legislative intent.
Senate Bill Report -1- ESHB 1097
products that were developed or manufactured using animal testing:
• California;
• Hawaii;
• Illinois;
• Louisiana;
• Maine;
• Maryland;
• Nevada;
• New Jersey;
• New York;
• Oregon; and
• Virginia.
Washington State statute is silent on the manufacture or development of cosmetics that use
cosmetic animal testing.
Summary of Bill: Manufacturers are prohibited from selling or offering for sale a cosmetic
if the cosmetic was developed or manufactured using cosmetic animal testing beginning
January 1, 2025.
A cosmetic is defined as articles intended to be rubbed, poured, sprinkled, or sprayed on,
introduced into or otherwise applied to the human body for the purpose of cleansing,
beautifying, promoting attractiveness, or altering one's appearance.
Exceptions. Manufacturers may sell a cosmetic developed or manufactured using cosmetic
animal testing conducted or contracted for by the manufacturer or its supplier when such
cosmetic animal testing is:
• conducted outside of the United States to comply with a foreign regulatory authority's
requirement, if evidence derived from the testing was not relied upon to substantiate
the safety of the cosmetic ingredient or cosmetic product sold by a manufacturer in
Washington;
• conducted for any cosmetic or cosmetic ingredient subject to regulation under
applicable portions of the FDCA;
• conducted for a cosmetic ingredient intended to be used in a noncosmetic product,
and is conducted under a federal, state, or foreign regulatory authority regulation, if
evidence derived from the testing was not relied upon to substantiate the safety of a
cosmetic sold in Washington, unless:
1. there is documented evidence of the noncosmetic intent of the test; and
2. there is history of the ingredient's use outside of cosmetics at least 12 months
before the reliance; or
• requested, required, or conducted by a federal or state regulatory authority and the
following additional criteria are satisfied:
1. there is no nonanimal alternative method or strategy recognized by any federal
or state agency or organization;
Senate Bill Report -2- ESHB 1097
2. the cosmetic ingredient or nonfunctional constituent poses a risk of causing a
specific human health problem that is substantiated, and the need to conduct
animal testing is justified and supported by a detailed research protocol; and
3. the cosmetic ingredient is in wide use and cannot be replaced by another
cosmetic ingredient capable of performing a similar function.
The prohibition on manufacturers selling a cosmetic developed or manufactured using
cosmetic animal testing conducted or contracted for by the manufacturer or its supplier does
not apply when:
• a cosmetic in its final form, or ingredient in a cosmetic, was tested on animals before
January 1, 2025, even if the cosmetic or ingredient is manufactured after January 1,
2025, provided that no new animal testing occurs after that date by or on the behalf of
the manufacturer; or
• a cosmetic manufacturer reviews, assesses, or retains evidence from a cosmetic
animal test.
Enforcement and Preemption. Manufacturers in violation of these regulations commit a civil
violation punishable by a fine up to $5,000 for each violation.
No political subdivision may establish or continue any prohibition on or relating to
cosmetic animal testing that is not identical to the prohibition established.
Appropriation: None.
Fiscal Note: Not requested.
Creates Committee/Commission/Task Force that includes Legislative members: No.
Effective Date: The bill takes effect on January 1, 2025.
Staff Summary of Public Testimony: PRO: This bill has received bipartisan support and
represents progress in the cosmetics industry. There are more options for testing that are
effective and do not require animal testing. Legislation like this is being implemented
worldwide. Oregon is the newest state among the 12 states that have enacted laws similar
to this. The unreliability of animal testing does not justify the extreme tests on animals.
Animals do not share physiology with humans, and the testing is not effective. More
accurate technology already exists. These methods cost hundreds of thousands of dollars
less and they are more accurate. This is the fourth year that we are working on this bill,
please schedule the bill for executive session. Cruel and archaic practices like smearing
ingredients on the skin of animals should not be allowed. Let's make Washington a more
caring and compassionate place. Not only is animal testing unnecessary, it is not a sure way
to ensure safety for humans. There is a global demand for products not tested on animals.
Manufacturing animal cruelty free cosmetics has been part of Lush Cosmetics vision for a
long time. We believe in funding better science. This bill has been drafted to mirror the
Senate Bill Report -3- ESHB 1097
Federal Humane Cosmetics Act.
Persons Testifying: PRO: Brenna Anderst, Pasado's Safe Haven/Education & Advocacy
Director; Amanda Fox, Animal Rights Initiative; Wendy Linton; Hannah Thompson-
Garner, Northwest Animal Rights Network (NARN); Hilary Pickles, Lush Fresh Handmade
Cosmetics; Dan Paul, The Humane Society of the United States; Wendy Linton.
Persons Signed In To Testify But Not Testifying: No one.
Senate Bill Report -4- ESHB 1097
File and source
- File
- 2024-02-20_a31985_d271770_bill-report-1097-s-e-sbr-bfgt-ta-24.pdf
- Size
- 11,115 bytes
- SHA-256
- 72b52d81754a5576de54e17bb99e666c7e585206e1114aae5dab0b49f45d65c0
- Original
- app.leg.wa.gov